1. Crawford PC, Dubovi EJ, Castleman WL, et al. Transmission of equine influenza virus to dogs. Science. 2005; 310:482–485.
Article
2. Song D, Kang B, Lee C, et al. Transmission of avian influenza virus (H3N2) to dogs. Emerg Infect Dis. 2008; 14:741–746.
Article
3. Center for Disease Control and Prevention. Key facts about canine influenza (dog flu). Atlanta, GA: Center for Disease Control and Prevention;2019.
4. Song DS, An DJ, Moon HJ, et al. Interspecies transmission of the canine influenza H3N2 virus to domestic cats in South Korea, 2010. J Gen Virol. 2011; 92(Pt 10):2350–2355.
Article
5. Kim H, Song D, Moon H, et al. Inter- and intraspecies transmission of canine influenza virus (H3N2) in dogs, cats, and ferrets. Influenza Other Respir Viruses. 2013; 7:265–270.
Article
6. Lyoo KS, Kim JK, Kang B, et al. Comparative analysis of virulence of a novel, avian-origin H3N2 canine influenza virus in various host species. Virus Res. 2015; 195:135–140.
Article
7. Sohrab SS, Suhail M, Kamal MA, Husen A, Azhar EI. Recent development and future prospects of plant-based vaccines. Curr Drug Metab. 2017; 18:831–841.
Article
8. Pillet S, Aubin E, Trepanier S, et al. A plant-derived quadrivalent virus like particle influenza vaccine induces cross-reactive antibody and T cell response in healthy adults. Clin Immunol. 2016; 168:72–87.
Article
9. Takeyama N, Kiyono H, Yuki Y. Plant-based vaccines for animals and humans: recent advances in technology and clinical trials. Ther Adv Vaccines. 2015; 3:139–154.
Article
10. Medicago. Pipeline. Quebec City: Medicago;2019.
11. Mappbio. Product development. San Diego, CA: Mapp Biopharmaceautical;2019.
12. Skehel JJ, Wiley DC. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem. 2000; 69:531–569.
Article
13. Grgacic EV, Anderson DA. Virus-like particles: passport to immune recognition. Methods. 2006; 40:60–65.
Article
14. D'Aoust MA, Lavoie PO, Couture MM, et al. Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice. Plant Biotechnol J. 2008; 6:930–940.
15. Cummings JF, Guerrero ML, Moon JE, et al. Safety and immunogenicity of a plant-produced recombinant monomer hemagglutinin-based influenza vaccine derived from influenza A (H1N1)pdm09 virus: a Phase 1 dose-escalation study in healthy adults. Vaccine. 2014; 32:2251–2259.
Article
16. Chichester JA, Jones RM, Green BJ, et al. Safety and immunogenicity of a plant-produced recombinant hemagglutinin-based influenza vaccine (HAI-05) derived from A/Indonesia/05/2005 (H5N1) influenza virus: a phase 1 randomized, double-blind, placebo-controlled, dose-escalation study in healthy adults. Viruses. 2012; 4:3227–3244.
Article
17. Shoji Y, Farrance CE, Bautista J, et al. A plant-based system for rapid production of influenza vaccine antigens. Influenza Other Respir Viruses. 2012; 6:204–210.
Article
18. Landry N, Pillet S, Favre D, et al. Influenza virus-like particle vaccines made in Nicotiana benthamiana elicit durable, poly-functional and cross-reactive T cell responses to influenza HA antigens. Clin Immunol. 2014; 154:164–177.
Article
19. Diamos AG, Rosenthal SH, Mason HS. 5′ and 3′ untranslated regions strongly enhance performance of geminiviral replicons in Nicotiana benthamiana leaves. Front Plant Sci. 2016; 7:200.
Article
20. Huang Z, Chen Q, Hjelm B, Arntzen C, Mason H. A DNA replicon system for rapid high-level production of virus-like particles in plants. Biotechnol Bioeng. 2009; 103:706–714.
Article
21. Huang Z, Phoolcharoen W, Lai H, et al. High-level rapid production of full-size monoclonal antibodies in plants by a single-vector DNA replicon system. Biotechnol Bioeng. 2010; 106:9–17.
Article
22. Kapusta J, Modelska A, Figlerowicz M, et al. A plant-derived edible vaccine against hepatitis B virus. FASEB J. 1999; 13:1796–1799.
Article
23. Pniewski T, Kapusta J, Bociag P, et al. Low-dose oral immunization with lyophilized tissue of herbicide-resistant lettuce expressing hepatitis B surface antigen for prototype plant-derived vaccine tablet formulation. J Appl Genet. 2011; 52:125–136.
Article
24. Govea-Alonso DO, Rubio-Infante N, Garcia-Hernandez AL, et al. Immunogenic properties of a lettuce-derived C4(V3)6 multiepitopic HIV protein. Planta. 2013; 238:785–792.
Article
25. Lai H, He J, Engle M, Diamond MS, Chen Q. Robust production of virus-like particles and monoclonal antibodies with geminiviral replicon vectors in lettuce. Plant Biotechnol J. 2012; 10:95–104.
Article
26. Santi L, Batchelor L, Huang Z, et al. An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles. Vaccine. 2008; 26:1846–1854.
Article
27. Zost SJ, Parkhouse K, Gumina ME, et al. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains. Proc Natl Acad Sci U S A. 2017; 114:12578–12583.
Article
28. An Y, Parsons LM, Jankowska E, Melnyk D, Joshi M, Cipollo JF. N-glycosylation of seasonal influenza vaccine hemagglutinins: implication for potency testing and immune processing. J Virol. 2019; 93:e01693–e01618.
Article
29. Gupta R, Jung E, Brunak S. Prediction of N-glycosylation sites in human proteins. NetNGlyc 1.0 Server. Lyngby: DTU Bioinformatics;2004.
30. Kalthoff D, Giritch A, Geisler K, et al. Immunization with plant-expressed hemagglutinin protects chickens from lethal highly pathogenic avian influenza virus H5N1 challenge infection. J Virol. 2010; 84:12002–12010.
Article
31. Phoolcharoen W, Dye JM, Kilbourne J, et al. A nonreplicating subunit vaccine protects mice against lethal Ebola virus challenge. Proc Natl Acad Sci U S A. 2011; 108:20695–20700.
Article
32. Chen Q, He J, Phoolcharoen W, Mason HS. Geminiviral vectors based on bean yellow dwarf virus for production of vaccine antigens and monoclonal antibodies in plants. Hum Vaccin. 2011; 7:331–338.
Article
33. Kwon KC, Nityanandam R, New JS, Daniell H. Oral delivery of bioencapsulated exendin-4 expressed in chloroplasts lowers blood glucose level in mice and stimulates insulin secretion in beta-TC6 cells. Plant Biotechnol J. 2013; 11:77–86.
Article
34. D'Aoust MA, Couture MM, Charland N, et al. The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza. Plant Biotechnol J. 2010; 8:607–619.
35. Future vaccine DARPA research. Arlingotn, VA: Defense Advanced Research Projects Agency;2012.